Real-Time Contrast-Enhanced-Guided Biopsy Compared with Conventional Ultrasound-Guided Biopsy in the Diagnosis of Hepatic Tumors on a Background of Advanced Chronic Liver Disease: A Prospective, Randomized, Clinical Trial.
暂无分享,去创建一个
Daniel Corneliu Leucuta | Ioana Rusu | Claudia Hagiu | Gabriel Kacso | Z. Sparchez | T. Mocan | C. Hagiu | Mihaela Sparchez | D. Leucuta | Zeno Sparchez | Tudor Mocan | Toader Zaharie | Nadim Al Hajjar | Mihaela Sparchez | G. Kacso | T. Zaharie | I. Rusu | N. al Hajjar | D. Leucuța | Mihaela Spârchez | Z. Spârchez
[1] I. Wanless,et al. Terminology of nodular hepatocellular lesions , 1995 .
[2] Ding‐Shinn Chen,et al. Ultrasound-guided cutting biopsy for the diagnosis of hepatocellular carcinoma--a study based on 420 patients. , 1996, Journal of hepatology.
[3] C. Fìlice,et al. Is second biopsy helpful in the diagnosis of hepatocellular carcinoma with a first negative biopsy? , 2000, American Journal of Gastroenterology.
[4] M. Bisceglia,et al. Diagnosis of Hepatocellular Carcinoma Complicating Liver Cirrhosis: Utility of Repeat Ultrasound-Guided Biopsy after Unsuccessful First Sampling , 2002, CardioVascular and Interventional Radiology.
[5] F. Klebl,et al. Contrast-enhanced ultrasound allows for interventions of hepatic lesions which are invisible on convential B-mode. , 2004, Zeitschrift für Gastroenterologie - German Journal of Gastroenterology.
[6] Wei Yang,et al. The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy. , 2006, AJR. American journal of roentgenology.
[7] J. Buckels,et al. Needle track seeding following biopsy of liver lesions in the diagnosis of hepatocellular cancer: a systematic review and meta-analysis , 2008, Gut.
[8] Won Jae Lee,et al. Planning sonography to assess the feasibility of percutaneous radiofrequency ablation of hepatocellular carcinomas. , 2008, AJR. American journal of roentgenology.
[9] J. Bruix,et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma , 2007, Hepatology.
[10] L. Forzenigo,et al. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis , 2009, Gut.
[11] Z. Sparchez,et al. B-mode and contrast enhanced ultrasound guided biopsy of portal vein thrombosis. Value in the diagnosis of occult hepatocellular carcinoma in liver cirrhosis. , 2010, Medical ultrasonography.
[12] K. Lee,et al. Real-time contrast-enhanced ultrasound-guided biopsy of focal hepatic lesions not localised on B-mode ultrasound , 2010, European Radiology.
[13] F. Durand,et al. Is tumor biopsy necessary? , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[14] Z. Sparchez,et al. Usefulness of contrast enhanced ultrasound guidance in percutaneous biopsies of liver tumors. , 2011, Journal of gastrointestinal and liver diseases : JGLD.
[15] G. Grazi,et al. Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment. , 2011, Journal of hepatology.
[16] B. Goldberg,et al. Radiological Clinical Practice Guidelines Published in the Last Decade: A Bibliometric Analysis , 2019, Journal of the Belgian Society of Radiology.
[17] L. Solbiati,et al. Intraprocedural contrast-enhanced ultrasound (CEUS) in liver percutaneous radiofrequency ablation: clinical impact and health technology assessment , 2014, Insights into Imaging.
[18] B. Zhai,et al. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results. , 2015, Ultrasound in medicine & biology.
[19] X. Cui,et al. EFSUMB Guidelines on Interventional Ultrasound (INVUS), Part II – Diagnostic Ultrasound-Guided Interventional Procedures (Long Version) , 2015, Ultraschall in der Medizin.
[20] Z. Sparchez,et al. Prospective comparison between real time contrast enhanced and conventional ultrasound guidance in percutaneous biopsies of liver tumors. , 2015, Medical ultrasonography.
[21] H. Seno,et al. Sonazoid-enhanced ultrasonography guidance improves the quality of pathological diagnosis in the biopsy of focal hepatic lesions , 2016, European journal of gastroenterology & hepatology.
[22] Jung-Hwan Yoon,et al. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma. , 2017, Journal of hepatology.
[23] Ivan Bricault,et al. EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice , 2017, Liver international : official journal of the International Association for the Study of the Liver.
[24] Z. Sparchez,et al. Contemporary role of liver biopsy in hepatocellular carcinoma , 2018, World journal of hepatology.
[25] Francesco Paolo Russo,et al. When and how should we perform a biopsy for HCC in patients with liver cirrhosis in 2018? A review. , 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[26] Sang Min Lee,et al. Clinical utility of real-time ultrasound-multimodality fusion guidance for percutaneous biopsy of focal liver lesions. , 2018, European journal of radiology.
[27] M. Ronot,et al. Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3 cm. , 2017, Journal of hepatology.
[28] M. Pompili,et al. Biopsy of Liver Target Lesions under Contrast-Enhanced Ultrasound Guidance – A Multi-Center Study , 2017, Ultraschall in der Medizin - European Journal of Ultrasound.
[29] A. Luciani,et al. Suspicious liver nodule in chronic liver disease: Usefulness of a second biopsy. , 2018, Diagnostic and interventional imaging.
[30] M. Lee,et al. A radiofrequency device for tract ablation after liver biopsy: a single-institution human feasibility study. , 2018, The British journal of radiology.
[31] P. Schirmacher,et al. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. , 2018, Journal of hepatology.